A Quality Improvement Initiative to Reduce Duplicate Inflammatory Marker Use.

ABSTRACT:

Introduction

Inflammatory markers (IMs) are often ordered in multiples, even though evidence suggests that this does not add any clinical benefit. The project aimed to reduce the number of duplicate IMs for patients by 10% in 12 months.

Methods

We implemented a quality improvement (QI) project at our hospital, focusing on patients admitted to the pediatric hospital medicine service. The team chose the model for improvement as the QI methodology. Key interventions included ongoing provider education, integrating the project into the physician incentive plan, and reviewing disease-specific pathways. The primary outcome measure was "duplicate IM use," which was defined as any two or more IMs (procalcitonin, C-reactive protein, or erythrocyte sedimentation rate) obtained on the

SUBMITTER: Bakkum KE 

PROVIDER: S-EPMC11412711 | biostudies-literature | 2024 Sep-Oct

REPOSITORIES: biostudies-literature